Title:
PLACEBO FOR USE WITH BIOLOGIC
Document Type and Number:
Japanese Patent JP2008120722
Kind Code:
A
Abstract:
To provide a placebo which is substantially identical with a biologic in appearance, is pharmaceutically safe, has no efficacy unlike a biologic, and is capable of being handled in the same manner as in an investigational new drug used in e.g., a double blind method.
The placebo for use with a biologic contains a substance having surface activity. Desirably, the placebo is one wherein the substance having surface activity is a surfactant.
Inventors:
OTANI KAZUHIRO
KIMURA KAZUYUKI
KUWABARA EIKI
KIMURA KAZUYUKI
KUWABARA EIKI
Application Number:
JP2006305703A
Publication Date:
May 29, 2008
Filing Date:
November 10, 2006
Export Citation:
Assignee:
BENESIS CORP
International Classes:
A61K49/00; A61K47/36; A61K47/46
Domestic Patent References:
JP2001525816A | 2001-12-11 | |||
JPH08504755A | 1996-05-21 |
Foreign References:
WO2005099776A2 | 2005-10-27 |
Other References:
JPN6012014590; MORELAND,L.W. et al: 'Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc f' N Engl J Med Vol.337, No.3, 1997, p.141-7
JPN7012001007; PMDA: 審査報告書 , 20041105
JPN6012014595; 大杉義征ら: 'キャッスルマン病治療薬,遺伝子組換えヒト化抗ヒトインターロイキン-6受容体抗体(トシリズマブ)の薬理学的' 日本薬理学雑誌 Vol.126, No.6, 2005, 419-25
JPN7012001008; 医薬食品局審査管理課: 審議結果報告書 , 20050228
JPN7012001007; PMDA: 審査報告書 , 20041105
JPN6012014595; 大杉義征ら: 'キャッスルマン病治療薬,遺伝子組換えヒト化抗ヒトインターロイキン-6受容体抗体(トシリズマブ)の薬理学的' 日本薬理学雑誌 Vol.126, No.6, 2005, 419-25
JPN7012001008; 医薬食品局審査管理課: 審議結果報告書 , 20050228
Attorney, Agent or Firm:
Takashima Ichi
Previous Patent: 重合性組成物及び成形体
Next Patent: SUPEROXIDE DISMUTASE EXPRESSION INDUCER AND FOOD AND DRINK CONTAINING THE EXPRESSION INDUCER
Next Patent: SUPEROXIDE DISMUTASE EXPRESSION INDUCER AND FOOD AND DRINK CONTAINING THE EXPRESSION INDUCER